ZeroG TRIP: Training Responses in Postural Rehabilitation
ZeroG TRIP:姿势康复训练反应
基本信息
- 批准号:9345110
- 负责人:
- 金额:$ 22.47万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2017
- 资助国家:美国
- 起止时间:2017-09-15 至 2019-08-31
- 项目状态:已结题
- 来源:
- 关键词:Adverse eventAgeAgingAlgorithmsBalance trainingBody WeightCharacteristicsClinicalComputersDevelopmentDevicesElderlyEquilibriumFeedbackGaitGait abnormalityGait speedGoalsImpairmentIndividualInjuryIntuitionLaboratoriesLaboratory StudyManualsMovementNeurologicParkinson DiseasePatientsPhasePostureQuality of lifeQuestionnairesRecruitment ActivityRehabilitation therapyResearch PersonnelRoboticsSafetySmall Business Innovation Research GrantSystemTabletsTechnologyTestingTrainingTranslatingVirginiaWalkingWireless TechnologyWorkbaseclinical practicedisabilityequilibration disorderexperiencefall riskfallsflexibilitygait rehabilitationhigh riskimprovedinnovationinstrumentationnervous system disorderphysical therapistpreventprototyperehabilitation technologyresearch clinical testingresponsesafety practicesensortouchscreenusability
项目摘要
Project Summary
The goal of this project is to significantly enhance our understanding and treatment of inadequate balance
responses in the elderly and in patients with neurological impairments following external perturbations such as
a slip or trip. Our laboratory studies have shown that balance responses can be improved with practice in the
elderly and in patients with Parkinson's disease (PD). However, these laboratory studies have not been
translated into clinical practice because there is currently no safe and reliable technology for training and
quantifying balance responses, particularly during overground walking. The ZeroG gait and balance training
system developed and now commercialized by Aretech, LLC (Ashburn, VA) allows individuals with gait and
balance disorders to safety practice walking overground with concurrent body-weight support and fall
protection. The current system does not allow patients to practice recovering from unexpected external
perturbation for balance training nor does the system contain the necessary instrumentation for quantifying
balance responses.
In this Phase I SBIR, we will significantly enhance the capabilities of the ZeroG system by developing
controlled balance perturbations of adjustable magnitude and direction that can be delivered during standing
and overground walking. The framework for the ZeroG balance perturbation sequences, called TRIP (Train
Responses in Postural Rehabilitation), will be based upon the scientific findings of our laboratory over the last
decade. We will develop the specific perturbation characteristics needed to train postural stepping responses
in people with balance deficits due to PD and work closely with physical therapists on usability and safety.
Finally, we will determine the feasibility and clinical usability of the ZeroG TRIP system through questionnaire
feedback from patients and therapists.
Phase II of this SBIR will focus on additional technical development of the ZeroG TRIP system and subsequent
clinical testing of the device. Specifically, we plan to develop and test innovative metrics of postural stepping
responses for ZeroG TRIP using the body-worn sensors with the partnership between Aretech, LLC and
APDM, Inc. We will also utilize the APDM sensors to track the patient's movements throughout the gait cycle
so that we can automatically trigger the TRIP perturbation rather than having to manually trigger the
perturbation. Finally, we will refine the user interfaces on both the touch screen computer and wireless tablet,
making the controls intuitive for the user yet providing sufficient flexibility to control the perturbation sequences.
The clinical testing during Phase II will focus on comparing improvements in balance responses and balance
confidence after training with TRIP compared to ZeroG body-weight support walking in people with PD.
The ZeroG TRIP system will enable physical therapists to safely and systematically assess and treat
inadequate balance responses, which are a major contributor to falls, disability, and declining quality of life.
项目摘要
这个项目的目标是显著提高我们对不充分平衡的理解和治疗
老年人和神经损伤患者在外部扰动后的反应,
滑倒或绊倒我们的实验室研究表明,平衡反应可以改善与实践中,
老年人和帕金森病(PD)患者。然而,这些实验室研究并没有被
转化为临床实践,因为目前没有安全可靠的技术进行培训,
量化平衡反应,特别是在地上行走期间。ZeroG步态和平衡训练
由Aretech,LLC(Ashburn,VA)开发并现已商业化的系统允许具有步态和
平衡障碍,安全练习地上行走,同时伴有体重支撑和跌倒
保护目前的系统不允许患者练习从意外的外部
该系统也不包含用于量化的必要仪器
平衡反应。
在第一阶段SBIR中,我们将通过开发
可在站立期间提供可调节幅度和方向的受控平衡扰动
和地上行走。ZeroG平衡扰动序列的框架,称为TRIP(Train
在姿势康复的反应),将基于我们的实验室在过去的科学发现
十年我们将开发训练姿势步进反应所需的特定扰动特性
在PD导致平衡缺陷的人群中,与物理治疗师密切合作,提高可用性和安全性。
最后,我们将通过问卷调查确定ZeroG TRIP系统的可行性和临床可用性
来自患者和治疗师的反馈。
该SBIR的第二阶段将侧重于零重力TRIP系统的额外技术开发,
器械的临床试验。具体来说,我们计划开发和测试创新的姿势步进指标
响应零TRIP使用身体佩戴传感器与合作伙伴之间的Aretech,LLC和
APDM公司我们还将利用APDM传感器来跟踪患者在整个步态周期中的运动
这样我们就可以自动触发TRIP扰动,而不必手动触发
扰动最后,我们将完善触摸屏电脑和无线平板电脑的用户界面,
使得控制对于用户来说是直观的,还提供足够的灵活性来控制扰动序列。
第二阶段的临床测试将集中在比较平衡反应和平衡的改善。
PD患者TRIP训练后的信心与ZeroG体重支持步行相比。
ZeroG TRIP系统将使物理治疗师能够安全和系统地评估和治疗
平衡反应不足,这是导致福尔斯、残疾和生活质量下降的主要因素。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Joseph M. Hidler其他文献
Joseph M. Hidler的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Joseph M. Hidler', 18)}}的其他基金
ZeroG: Dynamic over-ground body-weight support system
ZeroG:动态地面体重支撑系统
- 批准号:
8058926 - 财政年份:2009
- 资助金额:
$ 22.47万 - 项目类别:
ZeroG: Dynamic over-ground body-weight support system
ZeroG:动态地面体重支撑系统
- 批准号:
8250385 - 财政年份:2009
- 资助金额:
$ 22.47万 - 项目类别:
ZeroG: Dynamic Over-Ground Body-Weight Support System
ZeroG:动态地面体重支撑系统
- 批准号:
7671064 - 财政年份:2009
- 资助金额:
$ 22.47万 - 项目类别:
相似国自然基金
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
- 批准号:JCZRQN202500010
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
- 批准号:2025JJ70209
- 批准年份:2025
- 资助金额:0.0 万元
- 项目类别:省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
- 批准号:
- 批准年份:2024
- 资助金额:0 万元
- 项目类别:面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
- 批准号:2023JJ50274
- 批准年份:2023
- 资助金额:0.0 万元
- 项目类别:省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
- 批准号:
- 批准年份:2022
- 资助金额:33 万元
- 项目类别:地区科学基金项目
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
- 批准号:n/a
- 批准年份:2022
- 资助金额:10.0 万元
- 项目类别:省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
- 批准号:81973577
- 批准年份:2019
- 资助金额:55.0 万元
- 项目类别:面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
- 批准号:81602908
- 批准年份:2016
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
- 批准号:81501928
- 批准年份:2015
- 资助金额:18.0 万元
- 项目类别:青年科学基金项目
相似海外基金
The Phenomenon of Stem Cell Aging according to Methylation Estimates of Age After Hematopoietic Stem Cell Transplantation
根据造血干细胞移植后甲基化年龄估算干细胞衰老现象
- 批准号:
23K07844 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Analysis of Age-dependent Functional Changes in Skeletal Muscle CB1 Receptors by an in Vitro Model of Aging-related Muscle Atrophy
通过衰老相关性肌肉萎缩的体外模型分析骨骼肌 CB1 受体的年龄依赖性功能变化
- 批准号:
22KJ2960 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Joint U.S.-Japan Measures for Aging and Dementia Derived from the Prevention of Age-Related and Noise-induced Hearing Loss
美日针对预防与年龄相关和噪声引起的听力损失而导致的老龄化和痴呆症联合措施
- 批准号:
23KK0156 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Fund for the Promotion of Joint International Research (International Collaborative Research)
The Effects of Muscle Fatigability on Gait Instability in Aging and Age-Related Falls Risk
肌肉疲劳对衰老步态不稳定性和年龄相关跌倒风险的影响
- 批准号:
10677409 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Characterizing gut physiology by age, frailty, and sex: assessing the role of the aging gut in "inflamm-aging"
按年龄、虚弱和性别表征肠道生理学特征:评估衰老肠道在“炎症衰老”中的作用
- 批准号:
497927 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Deciphering the role of osteopontin in the aging eye and age-related macular degeneration
破译骨桥蛋白在眼睛老化和年龄相关性黄斑变性中的作用
- 批准号:
10679287 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Role of AGE/RAGEsignaling as a driver of pathological aging in the brain
AGE/RAGE信号传导作为大脑病理性衰老驱动因素的作用
- 批准号:
10836835 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Elucidation of the protein kinase NLK-mediated aging mechanisms and treatment of age-related diseases
阐明蛋白激酶NLK介导的衰老机制及年龄相关疾病的治疗
- 批准号:
23K06378 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Underlying mechanisms of age-related changes in ingestive behaviors: From the perspective of the aging brain and deterioration of the gustatory system.
与年龄相关的摄入行为变化的潜在机制:从大脑老化和味觉系统退化的角度来看。
- 批准号:
23K10845 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Targeting Age-Activated Proinflammatory Chemokine Signaling by CCL2/11 to Enhance Skeletal Muscle Regeneration in Aging
通过 CCL2/11 靶向年龄激活的促炎趋化因子信号传导以增强衰老过程中的骨骼肌再生
- 批准号:
478877 - 财政年份:2023
- 资助金额:
$ 22.47万 - 项目类别:
Operating Grants